美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,158.98

-13.5830-1.16%

漲家數：1

跌家數：6

平家數：- -

市盈率：- -

高：1,213.66

開：1,177.18

低：1,141.03

收：1,172.56

資料載入中...

輝瑞下跌5.04%，報21.49美元/股，總市值1218.80億美元

安進盤中異動臨近收盤股價大跌3.00%

諾和諾德盤中異動下午盤大幅跳水3.00%

輝瑞盤中異動大幅下挫3.00%報21.95美元

碩迪生物盤中異動早盤快速上漲7.97%

傳諾和諾德(NVO)擬提前在印度推出減肥藥Wegovy

諾和諾德4月7日成交額為9.18億美元

禮來4月7日成交額為44.80億美元

安進4月7日成交額為14.24億美元

諾和諾德據稱擬提前在印度推出減肥藥Wegovy

【歐股“十一羅漢”｜阿斯利康收跌超6.9%，阿斯麥跌2.5%跌幅最小，諾和諾德漲約0.5%】週一，阿斯麥控股荷蘭阿姆斯特丹股價收跌2.50%，報550.00歐元。諾和諾德哥本哈根股價收漲0.49%，報434.10。阿斯利康收跌6.96%，葛蘭素史克和羅氏製藥至少跌6%，諾華跌5.34%，賽諾菲、雀巢、德國思愛普Sap、LVMH集團跌4.78%-4.23%，歐萊雅跌3.96%。

諾和諾德豪擲10.9億美元加碼巴西產能劍指全球糖尿病與減重藥物需求激增

环球市场播报

諾和諾德CEO：將投資64億雷亞爾提高巴西工廠產能。

諾和諾德盤中異動早盤急速下挫3.04%

Altimmune, Inc.盤中異動股價大跌5.66%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1158.9794,"timestamp":1744142399999,"preClose":1172.5624,"halted":0,"volume":98332969,"delay":0,"changeRate":-0.011584,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":-13.583008,"latestTime":"04-08 16:00:00 EDT","open":1177.1805,"high":1213.6589,"low":1141.0305,"amount":6459248915.376059,"amplitude":0.06194,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1744185600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.432749,"peRate":33.288958,"turnoverRate":0.009314,"increases":1,"decrements":6,"flats":0,"marketCap":1239712460096,"floatMarketCap":1160110220464},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1213.6589,"amplitude":0.06194,"preClose":1172.5624,"low":1141.0305,"pbRate":"9.432749","latestPrice":1158.9794,"volume":98332969,"delay":0,"open":1177.1805,"prevYearClose":1305.0607,"prevWeekClose":1187.2208,"prevMonthClose":1314.3724,"prevQuarterClose":1314.3724,"fiveDayClose":1283.6255,"twentyDayClose":1351.7712,"sixtyDayClose":1332.8381,"secType":"PLATE","market":"US","turnoverRate":0.009314,"peRate":33.288958,"marketCap":1239712460096,"floatMarketCap":1160110220464,"timestamp":1744142399999,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":1,"down":6,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526840831","title":"輝瑞下跌5.04%，報21.49美元/股，總市值1218.80億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526840831","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526840831?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 03:45","pubTimestamp":1744141506,"startTime":"0","endTime":"0","summary":"4月9日，辉瑞盘中下跌5.04%，截至03:45，报21.49美元/股，成交12.41亿美元，总市值1218.80亿美元。财务数据显示，截至2024年12月31日，辉瑞收入总额636.27亿美元，同比增长6.84%；归母净利润80.31亿美元，同比增长279.0%。每天,世界各地的辉瑞员工致力于推进健康,以及能够应对他们这个时代最为棘手的疾病的预防和治疗方案。这与辉瑞作为一家世界领先的生物制药公司的责任是一致的。160多年来,辉瑞一直努力为人们提供更好、更优质的服务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/09034549405496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00BLSP4239.USD","LU0868494617.USD","LU1894683264.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0170899867.USD","BK4534","LU0306806265.USD","LU0225771236.USD","BK4550","LU1894683348.USD","SG9999001176.SGD","LU0321505439.SGD","LU1023059063.AUD","BK4592","PFE","BK4007","BK4599","LU0058720904.USD","BK4588","BK4585","IE00BBT3K403.USD","IE00BLSP4452.SGD","LU0289739699.SGD","SG9999002224.SGD","LU1057294990.SGD","SGXZ57979304.SGD","LU1066051498.USD","BK4581","LU1883839398.USD","LU0456855351.SGD","SG9999001176.USD","LU0985481810.HKD","BK4533","LU0225284248.USD","LU0321505868.SGD","SG9999003800.SGD","LU0306807586.USD","SG9999013999.USD","SG9999002232.USD","SG9999011175.SGD","IE0002270589.USD","LU0234572021.USD","IE00B19Z3581.USD","LU0122379950.USD","BK4568","LU1066053197.SGD"],"gpt_icon":1},{"id":"2526284767","title":"安進盤中異動 臨近收盤股價大跌3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526284767","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526284767?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 03:35","pubTimestamp":1744140934,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日03时35分，安进股票出现异动，股价快速下挫3.00%。截至发稿，该股报281.00美元/股，成交量230.569万股，换手率0.43%，振幅4.40%。最近的财报数据显示，该股实现营业收入332.32亿美元，净利润40.90亿美元，每股收益7.62美元，毛利213.33亿美元，市盈率37.21倍。安进股票所在的制药行业中，整体跌幅为0.97%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409033534aa2c6356&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409033534aa2c6356&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0289739699.SGD","LU0868494617.USD","BK4533","BK4599","IE0002141913.USD","LU0889565916.HKD","BK4566","IE00BJT1NW94.SGD","LU0058720904.USD","LU1057294990.SGD","LU0122379950.USD","LU2242652126.USD","LU2468319806.SGD","BK4585","BK4139","LU0109394709.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","AMGN","IE00BJJMRZ35.SGD","LU2112291526.USD","IE00B2B36J28.USD","LU1983299246.USD","LU1571399168.USD","LU1061106388.HKD","LU2089984988.USD","LU2242646821.SGD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU1023059063.AUD","BK4581","BK4588","BK4534","IE0009355771.USD"],"gpt_icon":0},{"id":"2526464018","title":"諾和諾德盤中異動 下午盤大幅跳水3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526464018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526464018?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 01:12","pubTimestamp":1744132345,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日01时12分，诺和诺德股票出现异动，股价快速下挫3.00%。诺和诺德股票所在的制药行业中，整体涨幅为0.29%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。健友股份在公告中表示，新批准产品近期将安排在美国上市销售，有望对公司经营业绩产生积极影响。据FDA官网，它是FDA批准的首个每日一次GLP-1 注射剂仿制药，用于糖尿病治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409011226a6b45baf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409011226a6b45baf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE00BKVL7J92.USD","BK4585","BK4532","NVO","IE00BZ1G4Q59.USD","BK4599","LU0154236417.USD","BK4588","LU1093756325.SGD","LU1093756168.USD"],"gpt_icon":1},{"id":"2526849320","title":"輝瑞盤中異動 大幅下挫3.00%報21.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526849320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526849320?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 01:03","pubTimestamp":1744131789,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日01时03分，辉瑞股票出现波动，股价快速下挫3.00%。截至发稿，该股报21.95美元/股，成交量3460.49万股，换手率0.61%，振幅4.60%。辉瑞股票所在的制药行业中，整体涨幅为0.38%。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。消息层面，截至01时03分，《高盛：下调Pfizer评级，由买入调整至中性评级, 目标价由32.00美元调整至25.00美元。》资讯为影响辉瑞的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409010309aa2c62dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409010309aa2c62dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002270589.USD","SG9999003800.SGD","BK4585","LU0122379950.USD","PFE","LU0306807586.USD","LU0868494617.USD","LU0985481810.HKD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4592","SG9999001176.USD","SG9999011175.SGD","BK4007","BK4568","LU0321505439.SGD","LU0225284248.USD","BK4588","LU0456855351.SGD","BK4533","SGXZ57979304.SGD","BK4550","IE00BLSP4452.SGD","LU1057294990.SGD","LU0170899867.USD","SG9999002232.USD","LU1894683348.USD","BK4599","LU1066053197.SGD","LU1883839398.USD","BK4581","LU1066051498.USD","SG9999002224.SGD","LU0225771236.USD","BK4534","LU0234572021.USD","SG9999013999.USD","SG9999001176.SGD","LU0058720904.USD","LU0306806265.USD","LU1023059063.AUD","LU1894683264.USD","IE00BBT3K403.USD","LU0321505868.SGD","IE00BLSP4239.USD","LU0289739699.SGD","IE000M9KFDE8.USD"],"gpt_icon":1},{"id":"2525155228","title":"碩迪生物盤中異動 早盤快速上漲7.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525155228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525155228?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 21:31","pubTimestamp":1744119084,"startTime":"0","endTime":"0","summary":"北京时间2025年04月08日21时31分，硕迪生物股票出现异动，股价快速上涨7.97%。截至发稿，该股报15.45美元/股，成交量5819股，换手率0.01%，振幅3.91%。硕迪生物股票所在的生物技术行业中，整体涨幅为1.42%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、Onconetix, Inc.、Cormedix Inc.涨幅较大，Onconetix, Inc.、60 Degrees Pharmaceuticals, Inc.、Naya Biosciences, Inc.较为活跃，换手率分别为712.48%、555.84%、40.99%，振幅较大的相关个股有居里、Cyclacel Pharmaceuticals, Inc.、Erasca, Inc.，振幅分别为11.21%、11.17%、10.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408213124aa2c61a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408213124aa2c61a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR","BK4599"],"gpt_icon":0},{"id":"2525883895","title":"傳諾和諾德(NVO)擬提前在印度推出減肥藥Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2525883895","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525883895?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 19:24","pubTimestamp":1744111448,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据外媒报道，继礼来(LLY)上月在印度推出其糖尿病和肥胖症药物Mounjaro后，丹麦制药商诺和诺德(NVO)正考虑在印度尽快推出其畅销减肥药Wegovy。报道指，诺和诺德原本计划于2026年推出该药物，目前正考虑今年或是未来几个月开始在印度销售Wegovy。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"287271","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4532","BK4599","BK4588","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","LU0154236417.USD","LU1093756168.USD","BK4007","NVO"],"gpt_icon":0},{"id":"2525138883","title":"諾和諾德4月7日成交額為9.18億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525138883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525138883?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 10:08","pubTimestamp":1744078131,"startTime":"0","endTime":"0","summary":"美东时间2025年4月7日，诺和诺德成交额为9.18亿美元，成交额较昨日增加33.26%，当日成交量为1455.19万股。诺和诺德于2025年4月7日涨1.74%，报63.64美元，该股过去5个交易日跌8.35%，年初至今跌25.13%，过去60日跌24.8%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408100859a6b36cba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408100859a6b36cba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","BK4532","LU0154236417.USD","LU1093756168.USD","NVO","BK4588","BK4599","IE00BZ1G4Q59.USD","LU1093756325.SGD","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2525883667","title":"禮來4月7日成交額為44.80億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525883667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525883667?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 09:48","pubTimestamp":1744076933,"startTime":"0","endTime":"0","summary":"美东时间2025年4月7日，礼来成交额为44.80亿美元，成交额较昨日增加13.19%，当日成交量为627.44万股。礼来于2025年4月7日跌1.96%，报723.73美元，该股过去5个交易日跌12.37%，年初至今跌6.09%，过去60日跌7.91%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-07|44.80亿|13.19%|627.44万|#|2025-04-04|39.58亿|85.61%|529.94万|#|2025-04-03|21.33亿|-2.06%|267.51万|#|2025-04-02|21.77亿|-9.71%|268.38万|#|2025-04-01|24.11亿|-21.07%|298.77万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408094900a451a351&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408094900a451a351&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2361045086.USD","SGXZ57979304.SGD","SG9999015978.USD","LU0823416689.USD","LU0471298777.SGD","LU1989771016.USD","LU2237443382.USD","LU2357305700.SGD","GB00BDT5M118.USD","LU2237443549.SGD","BK4581","LU0238689110.USD","LU1720051017.SGD","IE0002141913.USD","LU2361044949.HKD","LU2491050154.USD","IE00BK4W5L77.USD","IE00B2B36J28.USD","LU0094547139.USD","LU0006306889.USD","IE00BFTCPJ56.SGD","LU1917777945.USD","LU2468319806.SGD","LU1057294990.SGD","LU1093756168.USD","IE0004445239.USD","SG9999001176.USD","LU0456855351.SGD","LU1868836591.USD","LU1983299246.USD","IE00B4R5TH58.HKD","IE00BK4W5M84.HKD","IE00BJJMRZ35.SGD","LLY","LU2023250504.SGD","LU2552382058.USD","SG9999018857.SGD","LU0354030438.USD","SG9999015952.SGD","LU2265009873.SGD","SG9999014898.SGD","BK4599","LU0320765059.SGD","IE00BJLML261.HKD","LU0058720904.USD","IE00BJT1NW94.SGD","LU0109391861.USD","LU1127390331.HKD","SG9999014880.SGD","LU0203201768.USD"],"gpt_icon":1},{"id":"2525100254","title":"安進4月7日成交額為14.24億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525100254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525100254?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 09:16","pubTimestamp":1744074960,"startTime":"0","endTime":"0","summary":"美东时间2025年4月7日，安进成交额为14.24亿美元，成交额较昨日减少9.33%，当日成交量为492.30万股。安进于2025年4月7日跌1.6%，报289.69美元，该股过去5个交易日跌7.02%，年初至今涨12.04%，过去60日涨10.53%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408091609a4519585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408091609a4519585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1571399168.USD","LU2468319806.SGD","LU0289739699.SGD","BK4534","BK4533","IE00BJT1NW94.SGD","LU1023059063.AUD","BK4581","LU1057294990.SGD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU1983299246.USD","LU2089984988.USD","AMGN","LU2242652126.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00B4R5TH58.HKD","BK4585","SG9999001440.SGD","LU0320765992.SGD","BK4588","LU0122379950.USD","LU0889565916.HKD","BK4139","LU2242646821.SGD","IE00B2B36J28.USD","IE0002141913.USD","BK4566","LU0058720904.USD","LU2112291526.USD","BK4599","LU0868494617.USD"],"gpt_icon":0},{"id":"2525518004","title":"諾和諾德據稱擬提前在印度推出減肥藥Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2525518004","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525518004?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 09:03","pubTimestamp":1744074229,"startTime":"0","endTime":"0","summary":"格隆汇4月8日｜据路透，继礼来上月在印度推出其糖尿病和肥胖症药物Mounjaro后，丹麦制药商诺和诺德正考虑在印度尽快推出其畅销减肥药Wegovy。报道指，诺和诺德原本计划于2026年推出该药物，目前正考虑今年或是未来几个月开始在印度销售Wegovy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040809040494cecad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040809040494cecad6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4532","IE00BKVL7J92.USD","BK4585","LU1093756325.SGD","NVO","BK4599","LU1093756168.USD","BK4588","IE00BZ1G4Q59.USD","LU0154236417.USD"],"gpt_icon":0},{"id":"2525020801","title":"【歐股“十一羅漢”｜阿斯利康收跌超6.9%，阿斯麥跌2.5%跌幅最小，諾和諾德漲約0.5%】 週一，阿斯麥控股荷蘭阿姆斯特丹股價收跌2.50%，報550.00歐元。諾和諾德哥本哈根股價收漲0.49%，報434.10。阿斯利康收跌6.96%，葛蘭素史克和羅氏製藥至少跌6%，諾華跌5.34%，賽諾菲、雀巢、德國思愛普Sap、LVMH集團跌4.78%-4.23%，歐萊雅跌3.96%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2525020801","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525020801?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 02:00","pubTimestamp":1744048852,"startTime":"0","endTime":"0","summary":"周一，阿斯麦控股荷兰阿姆斯特丹股价收跌2.50%，报550.00欧元。诺和诺德哥本哈根股价收涨0.49%，报434.10。阿斯利康收跌6.96%，葛兰素史克和罗氏制药至少跌6%，诺华跌5.34%，赛诺菲、雀巢、德国思爱普Sap、LVMH集团跌4.78%-4.23%，欧莱雅跌3.96%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/08020049361011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0211331839.USD","LU1093756325.SGD","BK4532","BK4147","LU0345774391.USD","BK4183","AZN","BK4543","LU2456880835.USD","LU1734074674.USD","ASML","IE0004445239.USD","LU2417539215.USD","IE00BFTCPJ56.SGD","IE00BKVL7J92.USD","LRLCY","BK4585","BK4599","NVO","IE0002141913.USD","IE00BZ1G4Q59.USD","BK4212","IE00B2B36J28.USD","01477","LU0823434740.USD","BK4588","LU0097036916.USD","IE00B4R5TH58.HKD","GSK","BK4007","LU1829250122.USD","LU2462157665.USD","LU0070302665.USD","LU0320765489.SGD","LU0154236417.USD","LU0345774631.USD","GSK.UK","IE0009355771.USD","LU0320765992.SGD","LU0208291251.USD","BK4568","NSRGY","BK1191","BK1574","NVS","03165","LU1093756168.USD","LU2063271972.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2525026807","title":"諾和諾德豪擲10.9億美元加碼巴西產能 劍指全球糖尿病與減重藥物需求激增","url":"https://stock-news.laohu8.com/highlight/detail?id=2525026807","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525026807?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 23:39","pubTimestamp":1744040340,"startTime":"0","endTime":"0","summary":"据媒体报道，诺和诺德公司将在巴西投资109亿美元（约合60亿丹麦克朗），在巴西蒙特莫尔市现有工厂扩建生产基地，以提升核心产品聚焦GLP-1类降糖药Ozempic与减肥药Wegovy产能。\n\n　　预计该生产基地将在2028年前完成建设，创造500多个高技术岗位。\n　　诺和诺德在巴西提高降糖与减肥药产能的背景，是拉美糖尿病患病率已达10%，成为全球此类病患发病率最高的区域之一。\n　　巴西肥胖人口占比26%， Wegovy当地上市申请已进入最后阶段。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-04-07/doc-ineskiiq5581362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BZ1G4Q59.USD","BK4585","LU1093756325.SGD","BK4007","BK4532","LU0154236417.USD","BK4588","LU1093756168.USD","BK4599","IE00BKVL7J92.USD","NVO"],"gpt_icon":0},{"id":"2525040150","title":"諾和諾德CEO：將投資64億雷亞爾提高巴西工廠產能。","url":"https://stock-news.laohu8.com/highlight/detail?id=2525040150","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525040150?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 22:58","pubTimestamp":1744037908,"startTime":"0","endTime":"0","summary":"诺和诺德CEO：将投资64亿雷亚尔提高巴西工厂产能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/07225849360617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4599","BK4007","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO","BK4532","LU1093756168.USD","BK4585","BK4588","IE00BKVL7J92.USD","LU1093756325.SGD"],"gpt_icon":0},{"id":"2525171049","title":"諾和諾德盤中異動 早盤急速下挫3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525171049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525171049?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 21:43","pubTimestamp":1744033411,"startTime":"0","endTime":"0","summary":"北京时间2025年04月07日21时43分，诺和诺德股票出现异动，股价大幅跳水3.04%。截至发稿，该股报60.65美元/股，成交量195.236万股，换手率0.04%，振幅1.33%。诺和诺德股票所在的制药行业中，整体跌幅为4.56%。诺和诺德公司简介：诺和诺德拥有全球约三分之一的品牌糖尿病治疗市场，是全球领先的糖尿病护理产品供应商。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407214331aa2c5fa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407214331aa2c5fa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756168.USD","LU1093756325.SGD","BK4585","BK4588","BK4007","BK4532","NVO"],"gpt_icon":1},{"id":"2525046080","title":"Altimmune, Inc.盤中異動 股價大跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525046080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525046080?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 21:32","pubTimestamp":1744032722,"startTime":"0","endTime":"0","summary":"北京时间2025年04月07日21时32分，Altimmune, Inc.股票出现异动，股价大幅下挫5.66%。截至发稿，该股报4.00美元/股，成交量9.759万股，换手率0.13%，振幅0.94%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为1.83%。其相关个股中，天境生物、知临集团、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Transcode Therapeutics, Inc.、Tharimmune, Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为46.44%、20.17%、16.81%，振幅较大的相关个股有Xortx Therapeutics Inc.、Adverum Biotechnologies, Inc.、Oric Pharmaceuticals, Inc.，振幅分别为101.41%、98.06%、97.95%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407213203a450fadc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407213203a450fadc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4599","ALT","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":102,"code":"91000000","status":"200"}]}}